JUN
MOLECULAR TARGETJun proto-oncogene, AP-1 transcription factor subunit
JUN (Jun proto-oncogene, AP-1 transcription factor subunit) is targeted by 75 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting JUN
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 75 compounds. Use the BiohacksAI search to explore all JUN modulators.
About JUN as a Drug Target
JUN (Jun proto-oncogene, AP-1 transcription factor subunit) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 75 compounds with documented JUN interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
JUN inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.